End-stage renal disease, the final stage of all chronic kidney disorders, is associated with renal fibrosis and inevitably leads to renal failure and death. Transition of tubular epithelial cells (TECs) into mesenchymal fibroblasts constitutes a proposed mechanism underlying the progression of renal fibrosis and here we assessed whether protease-activated receptor (PAR)-1, which recently emerged as an inducer of epithelial-to-mesenchymal transition (EMT), aggravates renal fibrosis. We show that PAR-1 activation on TECs reduces the expression of epithelial markers and simultaneously induces mesenchymal marker expression reminiscent of EMT. We next show that kidney damage was reduced in PAR-1-deficient mice during unilateral ureter obstruction (UUO) and that PAR-1-deficient mice develop a diminished fibrotic response. Importantly, however, we did hardly observe any signs of mesenchymal transition in both wild-type and PAR-1-deficient mice suggesting that diminished fibrosis in PAR-1-deficient mice is not due to reduced EMT. Instead, the accumulation of macrophages and fibroblasts was significantly reduced in PAR-1-deficient animals which were accompanied by diminished production of MCP-1 and TGF-β. Overall, we thus show that PAR-1 drives EMT of TECs in vitro and aggravates UUO-induced renal fibrosis although this is likely due to PAR-1-dependent pro-fibrotic cytokine production rather than EMT.
pathogenesis of renal fibrosis. After injury, TECs undergo EMT in order to avoid imminent cell death and to aid tissue repair. [2] [3] [4] [5] Dysregulated repair due to persistent injury, however, leads to a switch from a regenerative process into a detrimental fibrotic response. 6 Although the concept of TECs undergoing mesenchymal transition upon kidney damage was raised more than a decade ago, the molecular mechanisms that control EMT of TECs remain largely unidentified.
Interestingly, the family of protease-activated receptors (PARs) recently emerged as key players in EMT. 7 PARs are G-protein coupled receptors that are activated by coagulation proteases thereby enabling these proteases to influence a range of pathophysiologic processes. 8 As opposed to classical G-protein coupled receptors, PAR activation requires proteolytic cleavage rather than ligand binding. Indeed, after proteolytic removal of the N-terminal extracellular region, a novel tethered ligand that interacts with the body of the receptor is unmasked.
Subsequent transmembrane signalling leads, amongst others, to EMT of alveolar epithelial cells and retinal pigment epithelial cells. [9] [10] [11] Moreover, PAR-1-dependent signalling drives fibroblast proliferation and extracellular matrix production in vitro, whereas PAR-1 deficiency limits liver, lung and skin fibrosis in experimental animal models. [12] [13] [14] [15] In the kidney, PAR-1 is expressed by endothelial cells, podocytes, mesangial cells, and tubular epithelial cells 16 and we recently showed that PAR-1 potentiates diabetic nephropathy by inducing mesangial cell proliferation and extracellular matrix production. 17 Based on the key role of PAR-1 in fibroproliferative disease, it is thus tempting to speculate that PAR-1 may be a key factor driving the pathogenesis of renal fibrosis. We challenged this hypothesis by evaluating renal fibrosis in wild-type and PAR-1-deficient mice subjected to the well-established murine unilateral ureter obstruction (UUO) model.
| MATERIALS AND METHODS

| Mice
PAR-1-deficient mice, generated on a C57Bl/6 background, were purchased from The Jackson Laboratory (Bar Harbor, ME, USA) whereas wild-type C57BL/6 mice were purchased from Charles River 
| Unilateral Ureter Obstruction Model
Thirty-two wild-type and 32 PAR-1-deficient C57Bl/6 mice were subjected to the UUO model as described before. 18, 19 Briefly, 8-week-old mice received preoperative analgesia (subcutaneous injection of 100 μg/kg buprenorphine (Temgesic, Shering-Plough)) and the right ureter was subsequently double ligated with 6.0 silk through a small abdominal incision under 2.0% isoflurane-induced anaesthesia.
Six wild-type and six PAR-1-deficient mice received a sham operation, in which all procedures were followed apart from ligation of the ureter. Expression levels were normalized using the average expression levels of β-actin, GAPDH and TBP. Primer sequences are listed in Table 1 .
| Western blot
Cells were seeded at a density of 20 000 cells/well in 24-well plates.
After stimulation for 24 hours, cells were washed in ice-cold PBS and lysed in Laemmli buffer. Kidney homogenates were lysed in Greenberger Lysis buffer. Lysates were next separated on 8%-12% SDS-PAGE gels and transferred onto Immobulin-P membranes (Millipore) as described before. 21 Membranes were blocked for 1 hour at room temperature in 5% bovine serum albumin (BSA) in TBS+0. 
| Immunocytochemistry
Cells were seeded at a density of 20 000 cells/well on coverslips in 24-well plates. After the indicated stimulation for 24-72 hours, cells
were washed in ice-cold PBS, fixed in 4% paraformaldehyde in PBS and stained as described before. 22 In 
| (Immuno)histochemistry
Formalin-fixed, paraffin-embedded, 4-μm-thick kidney slides were stained with periodic acid-Schiff-diastase (PAS-D) and picrosirius red following routine procedures. The PAS-D slides were subsequently scored by a pathologist in a blinded fashion as previously described. 18 Specific immunostainings were performed as described before 17 using the following antibodies: rat-anti-F4/80 (1:500; clone CI:A3-1, Serotec MCA497GA), rabbit-anti-vimentin (1:1000; #5741;
Cell Signaling), mouse-anti-α-SMA (1:800; 1A4; sc-32251; Santa (1:100) for 30 minutes at room temperature, visualized with DAB (BS04-999; Immunologic) and counterstained using haematoxylin.
Slides incubated without the primary antibody were used as negative controls to exclude non-specific binding of the secondary antibody. Microphotographs were taken at 20 times magnification using a Leica DM5000B microscope equipped with a Leica DFC500 camera and Image Pro Plus software (vs 5.02; Media Cybernatics).
| Statistics
All values are expressed as mean ± SEM. All groups were tested for normality using the D'Agostino-Pearson omnibus normality test.
Detected outliers were excluded from analysis. Differences between two groups were analysed using a t test if data were normally distributed, or a Mann-Whitney U test for non-parametric data. Multiple comparisons were analysed using one-way-ANOVA analysis or Kruskal-Wallis test (for nonparametric values), followed by Bonferroni's or Dunns multiple comparison tests, respectively. All analyses were performed using GraphPad Prism version 5.01.
| RESULTS
| PAR-1 activation induces EMT in tubular epithelial cells in vitro
To test the hypothesis that PAR-1 signalling induces EMT of TECs, 
| PAR-1 deficiency reduces UUO-induced renal fibrosis in mice
Based on our in vitro findings showing that PAR-1 activation triggers EMT of TECs, we hypothesized that PAR-1 would contribute to renal interstitial fibrosis. To prove or refute this hypothesis, PAR-1-deficient mice were subjected to UUO and fibrotic responses were compared to wild-type controls. We first assessed PAR-1 expression levels in control (contralateral) and obstructed kidney sections of wild-type mice. As shown in Figure 2A , PAR-1 expression is low in non-obstructed kidneys and significantly increases 7 and 10 days after the induction of UUO (which is in line with a recent study
showing PAR-1 induction after UUO using immunohistochemistry 23 ).
As expected, no PAR-1 mRNA was measured in the PAR-1-deficient mice during the experiment ( Figure 2A ). As shown in Figure 2B , Figure 3F , confirms that collagen I was significantly reduced in PAR-1-deficient mice. Finally, we show that diminished collagen deposition was not accompanied by reduced fibronectin production.
Although fibronectin mRNA levels were reduced in PAR-1-deficient mice compared to wild-type mice at t = 10, western blot analysis showed that protein levels did not differ between wild type and PAR-1-deficient mice ( Figure 3G ). Overall, these data show that PAR-1 deficiency limits UUO-induced fibroblast accumulation with subsequent collagen deposition.
WAASDORP ET AL.
| 1271
| No evidence that PAR-1 deficiency preserves the epithelial phenotype of tubular epithelial cells after UUO
It is tempting to speculate that the observed differences in vimentin and α-SMA levels between wild-type and PAR-1-deficient mice (Figure 3A , B) suggest that PAR-1 also drives EMT after the induction of UUO. Indeed, vimentin and α-SMA are both well-known markers of EMT, but vimentin and α-SMA expression may also originate from infiltrating/proliferating fibroblasts rather than from transitioned TECs. 24, 25 To discriminate between these processes, immunohistochemical analysis of α-SMA and vimentin was performed to localize the α-SMA and vimentin expressing cells. Interestingly, both these markers were mainly expressed in the renal interstitium and hardly any positive TEC was found ( Figure 4A, B) suggesting that the observed reduction of vimentin and α-SMA more likely reflects diminished interstitial fibroblast accumulation, rather than reduced EMT of TECs. Moreover, no difference in protein expression levels of the epithelial markers e-cadherin, SGLT2, and AQP-1 was observed between wild-type and PAR-1-deficient mice ( Figure 4C , D). Finally, we observed that SNAI1 expression (a transcription factor specific for EMT) was significantly induced at day 10 after the induction of UUO but no difference between wild-type and PAR-1-deficient mice was found ( Figure 4E ). Overall, we only observe minimal signs of EMT in both wild-type and PAR-1-deficient mice suggesting PAR-1-dependent EMT is of minor importance in UUO-induced pathology.
| PAR-1 stimulation leads to MCP-1 and TGF-β secretion
Next to its role in EMT, PAR-1 has also been implicated in the production of pro-fibrotic and/or pro-inflammatory mediators, like MCP-1 and TGF-β, during pulmonary fibrosis. 13, 26 To determine whether PAR-1 would play a role in the production of these pro-fibrotic and/ or pro-inflammatory mediators in the setting of renal fibrosis as well,
we assessed PAR-1-induced cytokine production by TECs in vitro. As shown in Figure 5A , thrombin-dependent PAR-1 activation induced expression levels of MCP-1, TGF-β1, and KC, but not of TNFα, IL6, or TGF-β3 in TECs. In line with these in vitro data, MCP-1 and TGF-β levels were also reduced in obstructed kidneys of PAR-1-deficient mice compared to obstructed kidneys of wild-type mice (Fig- ure 5B, C). Importantly, reduced MCP-1 levels in PAR-1 deficient obstructed kidneys were accompanied by a reduced influx of macrophages (shown as representative pictures in Figure 5E , and quantified by F4/80 expression as shown in Figure 5D ). Together, these data show that PAR-1 induces the expression of pro-fibrotic mediators with subsequent macrophage influx thereby providing an alternative explanation for the observed reduced renal fibrosis in PAR-1-deficient mice.
| DISCUSSION
Renal fibrosis is a life-threatening complication with limited treatment options and novel treatment options are thus eagerly awaited for. As EMT is postulated to contribute to the development of renal fibrosis 27 , we aimed to elucidate the relevance of PAR-1, a proposed mediator of EMT, during renal fibrosis. We show that PAR-1 activation induces EMT of proximal TECs in vitro and that PAR-1 deficiency limits renal fibrosis after experimental UUO. Diminished fibrosis in PAR-1-deficient mice is, however, not associated with reduced EMT but actually associates with diminished fibroblast accumulation and reduced pro-fibrotic cytokine production and macrophage recruitment.
To elucidate the underlying mechanism by which PAR-1 would Finally, expression levels of the key EMT transcription factor SNAI1
were also similar between wild-type and PAR-1-deficient mice.
Overall, we thus did not obtain any evidence that PAR-1 deficiency preserves the epithelial phenotype of tubular epithelial cells in vivo.
It is important to stress, however, that EMT is difficult to assess in vivo using (epithelial and/or mesenchymal) marker expression and F I G U R E 1 PAR-1 activation induces mesenchymal transition of imPTECs. A, Relative mRNA expression levels of AQP-1, ZO-1, vimentin, α-SMA, fibronectin, and collagen I in imPTECs 24 hours after stimulation with thrombin (1 U/mL) or TGF-Β (5 ng/mL). Indicated is the average of three independent experiments. *P < 0.05, **P < 0.01, ***P < 0.005 (one-way ANOVA followed by Bonferroni multiple comparisons test). B, Protein expression levels of AQP-1, ZO-1, vimentin, α-SMA, fibronectin, and collagen I in imPTEC whole cell lysates 72 h after stimulation with thrombin (1 U/mL), TRAP-6 (100 μM), or TGF-Β (5 ng/mL). GAPDH or β-actin expression served as a loading control. C: Representative images of imPTECs 72 h after stimulation with thrombin (1 U/ml), TRAP-6 (100 μM), or TGF-Β (0.5 ng/mL). Blue: DAPI, red: phalloidin, and green: α-SMA (upper panels) and ZO-1 (lower panels) actually may only be quantitatively assessed using cell fade tracing studies. 25, 28 Despite the lack of effect of PAR-1 on EMT observed in vivo, fibroblast accumulation and collagen deposition were clearly dimin- ) mice, 7 and 10 d after UUO. GAPDH expression served as loading control. *P < 0.05; **P < 0.01; ***P < 0.005; ****P < 0.001 (one-way ANOVA followed by Bonferroni multiple comparisons test) F I G U R E 2 General evaluation of renal damage after UUO. A, PAR-1 mRNA expression in kidney lysates of contralateral and obstructed (UUO) kidneys from wild-type and PAR-1-deficient mice 1, 3, 7, and 10 d after UUO. B, Tubular injury score of PAS-D-stained kidney sections of mice killed at the indicated time points after the induction of UUO. *P < 0.05; **P < 0.01; (one-way ANOVA followed by Bonferroni multiple comparisons test) ) mice, 7 and 10 d after UUO. *P < 0.05; **P < 0.01; ***P < 0.005; ****P < 0.001 (one-way ANOVA followed by Bonferroni multiple comparisons test) was suppressed in UUO mice treated with the specific FXa inhibitor edoxaban. 23 Although this may pinpoint FXa as the endogenous PAR-1 agonist driving PAR-1-dependent renal injury during UUO, it was not shown that the effect of FX inhibition was PAR-1 dependent.
Overall, we here show that PAR-1 contributes to renal fibrosis, as evident from increased fibroblast accumulation and collagen deposition in the interstitial areas of wild-type kidneys compared to PAR-1-deficient kidneys, and could therefore be a potential target to pur- 
